Skip to content
Adam Torkildson – Lifestyle
Author:
CereVasc, Inc.
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
June 4, 2026